Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Zurzuvae™ (zuranolone) – New drug approval
August 4, 2023 - The FDA announced the approval of Biogen and Sage Therapeutics’ Zurzuvae (zuranolone), for the treatment of postpartum depression (PPD) in adults.
